US$ 28.92
semaglutide and loratadine Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Does anyone else have a
Description
However, experts note there is no scientific evidence to support this claim

Some patients prefer injecting in the evening when they can rest if side effects occur, while others inject in the morning to avoid evening injection site reactions interfering with sleep
BMJ Open Diabetes Research & Care

But you're not hungry

This slows gastric emptying (keeping you fuller longer), reduces cravings, and enhances fat burning
The decision to increase hinges on your blood sugar readings, tolerability, and clinical goals set with your healthcare provider